| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.07B | $1.05B | $821.2M |
| YoY Revenue Growth % | +96.4% | +28.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $707.0M | $164.2M | -$38.7M |
| Operating Margin % | 34.2% | 15.6% | -4.7% |
| Net Income (GAAP) | $585.9M | $58.9M | -$103.6M |
| EBITDA (Normalized) | $781.5M | $202.1M | -$9.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $886.9M | $174.2M | $67.3M |
| Capital Expenditures (CapEx) | $93.2M | $47.4M | $37.0M |
| Free Cash Flow (FCF) | $793.7M | $126.8M | $30.3M |
| FCF Margin % | 38.3% | 12.0% | 3.7% |
| Return on Invested Capital (ROIC %) | 14.5% | 8.1% | -0.6% |
| Cash & Short-Term Equivalents | $553.6M | $55.1M | — |
| Total Debt (Short + Long Term) | $1.10B | $538.6M | $1.86B |
| Total Stockholders' Equity | $3.31B | $1.12B | $3.81B |